Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tartaric Acid SCHEMBL31024302 | 1.00 | HSD17B10 (0.49) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| Tartaric Acid SCHEMBL30165576 | 1.00 | HSD17B10 (0.49) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| SCHEMBL25087871 | 0.90 | HSD17B10 (0.48) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| SCHEMBL376570 | 0.90 | HSD17B10 (0.48) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| Hydrochloric Acid SCHEMBL21523427 | 0.89 | HSD17B10 (0.47) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| Hydrochloric Acid SCHEMBL21523430 | 0.89 | HSD17B10 (0.47) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| SCHEMBL25424454 | 0.85 | HSD17B10 (0.47) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| SCHEMBL25424456 | 0.85 | HSD17B10 (0.47) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| Hydrochloric Acid SCHEMBL25424490 | 0.84 | HSD17B10 (0.46) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A | |
| Hydrochloric Acid SCHEMBL25424488 | 0.84 | HSD17B10 (0.46) | HSD17B10ALDH1A1MAPTKMT2AFKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118139835-A | Method for preparing apoptosis inducer | 艾伯维公司 | 2024-06-04 | — | — | CN | claimed |
| CN-118139835-A | Method for preparing apoptosis inducer | 艾伯维公司 | 2024-06-04 | — | — | CN | disclosed |